drugset / Trial / NCT06141577
A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized, open-label, multiple-dose crossover phase 1 clinical trial to compare and evaluate the safety, pharmacokinetics and pharmacodynamics characteristics after oral administration of UI059 and UIC202201 in healthy adult volunteers
Timeline
- Start
- 2023-10-08
- Primary completion
- 2023-11-07
- Completion
- 2023-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UI059 | Unknown | — | Oral |
| Comparator | UIC202201 | Unknown | — | Oral |